Skip to main content
. 2020 May 12;319(1):E187–E195. doi: 10.1152/ajpendo.00058.2020

Fig. 3.

Fig. 3.

Glucose:β-hydroxybutyrate (βOHB) ratio. A: the glucose-ketone ratio (glucose:βOHB) was elevated in nonalcoholic fatty liver disease (NAFLD) compared with Controls (Basal; Control: 33.8 ± 8.8; NAFLD: 44.9 ± 10.4; P = 0.02). BD: glucose:βOHB was elevated with higher body fat percentage (B) and poorer glucose control evidenced by elevated HbA1c (C) and impaired insulin sensitivity (D).